Back

Lipoprotein-(a) and mitral annular calcification: a systematic review and meta-analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Lipids (3) Lipids ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Konstantinos Kyriakoulis

National & Kapodistrian University of Athens Medical School, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia
Doctor H. Tada (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
The effect of baseline prediabetes on the relation between lipoprotein (a) and incident type 2 diabetes and outcome: observations from the UK-Biobank.
Doctor J. Sangha (Cambridge, GB)
Abstract Slides Video
Presentation thumbnail
Unmet needs of LDL C lowering in ACS patients when using only high intensity statins puts at setback
Doctor S. Ramraika (Lucknow, IN)
Abstract Slides Video
Presentation thumbnail
Longitudinal impact of lipid levels on subclinical atherosclerosis in adolescents: insights from the LOOK study
Doctor C. Abhayaratna (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
The determinants of lack of atherosclerosis progression in adult patients with elevated lipoprotein(a). The results from the STAR-Lp(a) study.
Professor M. Banach (Lodz, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids (3)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Lipoprotein(a) levels and LPA genotypes are not associated with echocardiographic measures of left ventricular structure and function in the general population
thumbnail
Congress Presentation
Abscence of high lipoprotein(a) levels is and independent predictor of acute myocardial infarction without coronary lesions
thumbnail
Congress Presentation
Lipoprotein(a), high-sensitive c reactive protein, and long-term survival after coronary artery bypass grafting

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources